<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00345124</url>
  </required_header>
  <id_info>
    <org_study_id>med.res.hos.2006.cc.02</org_study_id>
    <nct_id>NCT00345124</nct_id>
  </id_info>
  <brief_title>The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension</brief_title>
  <official_title>The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension, During Basal Conditions and After Hypertonic Saline Infusion.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regional Hospital Holstebro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to test the following hypotheses:

        -  that the function and/or regulation of AQP2 and/or ENaC in the principal cells is
           abnormal in essential hypertension.

        -  if an abnormal function of the principal cells is present in essential hypertension,
           this will become more pronounced at high and low sodium intake.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>u-AQP-2</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fractional sodium excretion</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>p-vasopressin</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>p-aldosterone</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>u-p-AQP-2</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>u-ENaC(alfa,beta,gamma)</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CH2O</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>u-cAMP</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>uPGE2</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GFR</measure>
    <time_frame>Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Essential Hypertension and Healthy Controls</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>high sodium diet</intervention_name>
    <description>250-350 mmol</description>
    <other_name>For four days</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Sodium Diet</intervention_name>
    <description>25-35 mmol</description>
    <other_name>For four days</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Caucasian men and women

          -  Age 18-65 years

          -  Arterial hypertension

          -  Body mass index between 18.5 and 30 kg/m2

        Exclusion Criteria:

          -  Secondary hypertension

          -  Isolated systolic hypertension

          -  History or clinical signs of AMI, atrial fibrillation, disease of the heart valves, or
             chronic heart failure.

          -  Malignant disease

          -  Prior apoplexy

          -  alcohol or drug abuse

          -  Drug use except antihypertensives and oral contraceptives

          -  Abnormal biochemical screening of the blood regarding: red and white blood count,
             s-creatinine (&gt; 200 micromol/L), b-hemoglobin, p-Sodium, p- potassium, p-albumine,
             p-bilirubin, p-alanine aminotransferase, p-alkaline phosphatase, p-cholesterol and
             b-glucose.

          -  Abnormal screening of the urine regarding: Blood, albumine and glucose.

          -  abnormal electrocardiogram

          -  Blood donation within one month of the first examination day

          -  Unwillingness to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erling B. Pedersen, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Medical Research, Holstebro Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carolina C. Graffe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medical Research, Holstebro Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medical Research, Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2006</study_first_submitted>
  <study_first_submitted_qc>June 24, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2006</study_first_posted>
  <last_update_submitted>June 27, 2011</last_update_submitted>
  <last_update_submitted_qc>June 27, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2011</last_update_posted>
  <responsible_party>
    <name_title>Carolina Cannillo Graffe</name_title>
    <organization>Department of Medical Research, Holstebro Hospital</organization>
  </responsible_party>
  <keyword>urinary aquaporin-2</keyword>
  <keyword>ENaC</keyword>
  <keyword>fractional sodium excretion</keyword>
  <keyword>High/low sodium diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>November 1, 2012</submitted>
    <returned>November 30, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

